Open and forthcoming calls listed on the EU Funding and Tenders Portal, sorted by the next deadline.
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 8.0 to 10.0 million per grant, about 4 grants expected (2027).
Funds research into personalised approaches to reduce adverse drug reactions caused by administration of multiple medications, integrating genetic and biomarker information into clinical decision making to improve patient safety, health outcomes, and cost efficiency in healthcare systems.
Official topic page: HORIZON-HLTH-2027-01-CARE-02
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 9.0 to 11.0 million per grant, about 5 grants expected (2027).
Funds research and innovation to develop novel small molecule antiviral therapeutics targeting pathogens with epidemic potential, aiming to expand therapeutic options and improve preparedness for emerging or re-emerging viral outbreaks accelerated by climate change.
Official topic page: HORIZON-HLTH-2027-01-DISEASE-05
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 9.0 to 10.0 million per grant, about 4 grants expected (2027).
Official topic page: HORIZON-HLTH-2027-01-DISEASE-06
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 9.0 to 10.0 million per grant, about 4 grants expected (2027).
Funds the development of monoclonal antibodies targeting Filo-, Nairo-, Phenui-, Picorna- and Togaviruses, aiming to deliver candidate therapies for prevention and treatment of emerging or re-emerging viral infections with epidemic or pandemic potential.
Official topic page: HORIZON-HLTH-2027-01-DISEASE-07
Development of innovative antimicrobials against pathogens resistant to antimicrobials
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 8.0 to 10.0 million per grant, about 5 grants expected (2027).
Funds development of innovative antimicrobial products against drug-resistant bacteria and fungi, aiming to expand therapeutic options and strengthen the clinical response to the growing threat of antimicrobial resistance.
Official topic page: HORIZON-HLTH-2027-01-DISEASE-08
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 3.0 to 4.0 million per grant, about 3 grants expected (2027).
Funds research on prevention and management of chronic non-communicable diseases in children and young people, particularly in low- and middle-income countries and disadvantaged populations, aiming to improve early prevention, diagnosis, and quality of life. Aligned with the Global Alliance for Chronic Diseases.
Official topic page: HORIZON-HLTH-2027-01-DISEASE-10
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 10.0 to 11.0 million per grant, about 4 grants expected (2027).
Funds research integrating climate-related exposures into the human exposome framework, aiming to improve understanding of how climatic, environmental and socio-behavioural factors interact to affect health outcomes and to support climate-resilient public health strategies.
Official topic page: HORIZON-HLTH-2027-01-ENVHLTH-02
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 6.0 to 8.0 million per grant, about 4 grants expected (2027).
Funds development of cell-free protein synthesis platforms for discovering and producing peptide- or protein-based biologicals, aiming to streamline biopharmaceutical production processes and improve patient access to affordable medicines.
Official topic page: HORIZON-HLTH-2027-01-IND-01
Addressing disabilities through the life course to support independent living and inclusion
Open, closes 17 February 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 6.0 to 8.0 million per grant, about 5 grants expected (2027).
Funds research on addressing disabilities across the life course, aiming to develop innovative solutions that remove barriers to independent living, community inclusion, and equal participation in society for persons with long-term disabilities.
Official topic page: HORIZON-HLTH-2027-01-STAYHLTH-01
Innovative healthcare interventions for non-communicable diseases
Open: stage 1 closes 17 February 2027; stage 2 closes 16 September 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 7.0 to 8.0 million per grant, about 8 grants expected (2027).
Funds research and innovation to develop and validate innovative healthcare interventions for non-communicable diseases, specifically cardiovascular diseases, diabetes, chronic respiratory diseases, or chronic kidney diseases, through late-stage clinical trials and FAIR data sharing.
Official topic page: HORIZON-HLTH-2027-02-DISEASE-01-two-stage
Clinical trials for advancing innovative interventions for neurodegenerative diseases
Open: stage 1 closes 17 February 2027; stage 2 closes 16 September 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: around EUR 10.0 million per grant, about 4 grants expected (2027).
Official topic page: HORIZON-HLTH-2027-02-DISEASE-14-two-stage
Portable and versatile Point-of-care diagnostics
Open: stage 1 closes 17 February 2027; stage 2 closes 16 September 2027. HORIZON-IA HORIZON Innovation Actions. Indicative budget: EUR 5.0 to 7.0 million per grant, about 6 grants expected (2027).
Official topic page: HORIZON-HLTH-2027-02-IND-02-two-stage
Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Open: stage 1 closes 17 February 2027; stage 2 closes 16 September 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 6.0 to 8.0 million per grant, about 6 grants expected (2027).
Funds the development of predictive biomarkers for disease progression and treatment response in chronic non-communicable diseases using AI methodologies, aiming to advance personalised medicine and improve clinical outcomes through validated, trustworthy tools.
Official topic page: HORIZON-HLTH-2027-02-TOOL-01-two-stage
Advancing bio-printing of living cells for regenerative medicine
Opens 3 June 2027, closes 16 September 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 7.0 to 10.0 million per grant, about 4 grants expected (2027).
Funds research and innovation to advance bio-printing of living cells for regenerative medicine, aiming to deliver functional tissue-specific 3D bio-printing units for transplantation applications and enable personalised treatments for conditions of unmet medical need.
Official topic page: HORIZON-HLTH-2027-03-TOOL-02
Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Opens 3 June 2027, closes 16 September 2027. HORIZON-RIA HORIZON Research and Innovation Actions. Indicative budget: EUR 10.0 to 12.0 million per grant, about 4 grants expected (2027).
Funds research developing Virtual Human Twin models as multi-scale, multi-organ digital representations of individual patients to support integrated clinical decision-making in prevention and diagnosis, improving personalised care across diverse patient populations.
Official topic page: HORIZON-HLTH-2027-03-TOOL-04
Towards the next generation of frontier Artificial Intelligence models for healthcare
Opens 3 June 2027, closes 16 September 2027. HORIZON-CSA HORIZON Coordination and Support Actions. Indicative budget: around EUR 2.9 million per grant, one grant expected (2027).
Funds coordination and support activities to build a collaborative roadmap for developing next-generation frontier AI models for healthcare, improving understanding of how to use AI Factories, foundation models, and highly heterogeneous multimodal health data for inclusive and personalised medicine.
Official topic page: HORIZON-HLTH-2027-03-TOOL-08
Titles, identifiers, types of action, dates and indicative budgets come from the
EU Funding and Tenders Portal; statuses are as of the date at the top of the page. Deadlines are usually at 17:00 Brussels time: confirm each call's status, conditions and exact deadline time on its official topic page before you rely on it. Call summaries are drafted and checked automatically by a computational system from each call's official description; they are not individually reviewed by a person. Cedulor is independent and not affiliated with the European Union or its research bodies.
Preparing a proposal? Cedulor takes you from a conversation about your project to a Part B document.